"Trypanocidal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.
| Descriptor ID |
D014344
|
| MeSH Number(s) |
D27.505.954.122.250.100.875
|
| Concept/Terms |
Trypanocidal Agents- Trypanocidal Agents
- Agents, Trypanocidal
- Trypanocidal Drugs
- Drugs, Trypanocidal
- Trypanosomicides
- Trypanocides
- Trypanosomicidal Agents
- Agents, Trypanosomicidal
|
Below are MeSH descriptors whose meaning is more general than "Trypanocidal Agents".
Below are MeSH descriptors whose meaning is more specific than "Trypanocidal Agents".
This graph shows the total number of publications written about "Trypanocidal Agents" by people in this website by year, and whether "Trypanocidal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 4 | 1 | 5 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Trypanocidal Agents" by people in Profiles.
-
World Chagas Disease Day and the New Road Map for Neglected Tropical Diseases. Curr Top Med Chem. 2020; 20(17):1518-1520.
-
Recognition for Chagas disease. Lancet Infect Dis. 2019 07; 19(7):699.
-
Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study. PLoS Negl Trop Dis. 2018 11; 12(11):e0006814.
-
A new antitrypanosomal alkaloid from the Red Sea marine sponge Hyrtios sp. J Antibiot (Tokyo). 2018 11; 71(12):1036-1039.
-
Congenital Chagas disease in a non-endemic area: Results from a control programme in Bergamo province, Northern Italy. Travel Med Infect Dis. 2018 Sep - Oct; 25:31-34.
-
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect Immun. 2018 04; 86(4).
-
A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda. Parasit Vectors. 2018 02 22; 11(1):105.
-
4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2017 12; 11(12):e0006132.
-
Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease. PLoS One. 2017; 12(9):e0185033.
-
Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei. Bioorg Med Chem Lett. 2017 08 15; 27(16):3629-3635.